FDA Takes Action Against Propoxyphene But Keeps It On The Market
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA denies Public Citizen's request for withdrawal, instead mandating new studies to assess propoxyphene's link to overdoses and requiring a boxed warning and MedGuide.